vercyte
Pharmaranks rates Vercyte 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Vercyte (Pipobroman) is a medication used to treat Leukemia, Polycythemia Vera.
Pipobroman · by Abbott
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Pipobroman
- Form
- Tablet
- Strength
- Pipobroman 10MG · Pipobroman 25MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- leukemia, polycythemia vera
- Manufacturer
- Abbott
- FDA application
- NDA016245
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Vercyte treat?
- Vercyte (Pipobroman) may be used to treat leukemia, polycythemia vera, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Vercyte rated?
- pharmaranks gives Vercyte a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Vercyte?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Vercyte. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Vercyte?
- Vercyte is marketed by Abbott. You can see Abbott's full profile, rating, and other products on pharmaranks.
- Is Vercyte a brand-name or generic drug?
- Vercyte is a brand-name product with the active ingredient Pipobroman.
- Is Vercyte available over the counter?
- No. Vercyte is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Vercyte come in?
- Vercyte is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Vercyte FDA-registered?
- Vercyte is on record with the U.S. FDA under application number NDA016245. You can verify this on its official FDA label.
- Has Vercyte been recalled by the FDA?
- Vercyte has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Vercyte safe?
- There's no single safe-or-not verdict. pharmaranks gives Vercyte a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about PIPOBROMAN
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 34 reports naming PIPOBROMAN — the active ingredient in Vercyte, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- hepatitis5 reports
- sleep apnoea syndrome5 reports
- bone tuberculosis4 reports
- amyotrophic lateral sclerosis3 reports
- thrombocytopenia3 reports
- anaemia2 reports
- arthralgia2 reports
- asthenia2 reports
Read these as a signal, not a rate. A report does not mean PIPOBROMAN caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 27, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
anagrelide hydrochloride
Anagrelide Hydrochloride
cytarabine
Cytarabine
camptosar
Irinotecan Hydrochloride
absorica
Isotretinoin
absorica ld
Isotretinoin
agrylin
Anagrelide Hydrochloride
Compare Vercyte head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
vercyte
72/100